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Abstract
Purpose: To assess cardiothoracic structure and function in patients with pectus excavatum compared with
control subjects using cardiovascular magnetic resonance imaging (CMR).
Method: Thirty patients with pectus excavatum deformity (23 men, 7 women, age range: 14-67 years) underwent
CMR using 1.5-Tesla scanner (Siemens) and were compared to 25 healthy controls (18 men, 7 women, age range
18-50 years). The CMR protocol included cardiac cine images, pulmonary artery flow quantification, time resolved
3D contrast enhanced MR angiography (CEMRA) and high spatial resolution CEMRA. Chest wall indices including
maximum transverse diameter, pectus index (PI), and chest-flatness were measured in all subjects. Left and right
ventricular ejection fractions (LVEF, RVEF), ventricular long and short dimensions (LD, SD), mid-ventricle myocardial
shortening, pulmonary-systemic circulation time, and pulmonary artery flow were quantified.
Results: In patients with pectus excavatum, the pectus index was 9.3 ± 5.0 versus 2.8 ± 0.4 in controls (P < 0.001).
No significant differences between pectus excavatum patients and controls were found in LV ejection fraction, LV
myocardial shortening, pulmonary-systemic circulation time or pulmonary flow indices. In pectus excavatum,
resting RV ejection fraction was reduced (53.9 ± 9.6 versus 60.5 ± 9.5; P = 0.013), RVSD was reduced (P < 0.05)
both at end diastole and systole, RVLD was increased at end diastole (P < 0.05) reflecting geometric distortion of
the RV due to sternal compression.
Conclusion: Depression of the sternum in pectus excavatum patients distorts RV geometry. Resting RVEF was
reduced by 6% of the control value, suggesting that these geometrical changes may influence myocardial
performance. Resting LV function, pulmonary circulation times and pulmonary vascular anatomy and perfusion
indices were no different to controls.
Introduction
Patients with pectus excavatum, a relatively common
congenital deformity, often present with symptoms such
as exertional dyspnea, fatigue, chest discomfort or palpi-
tations. The suggested etiology for this abnormality,
although uncertain, has been described as an overgrowth
of the costal cartilages in utero, usually ribs 4, 5, 6, 7,
and 8, which then limits the elevation of the sternum
[1]. Posterior invagination of the sternum shifts the
heart further into the left hemithorax and may distort
the shape of the heart and adjacent great veins. Some
investigators have reported that the deformed chest is
responsible for cardiopulmonary impairment in sympto-
matic patients. To date, the major evidence for this
assertion has been symptomatic improvement after sur-
gery, manifest in enhancement of exercise performance
and increased oxygen pulse (a physiological measure
that reflects cardiac stroke volume). Haller et al [2] have
concluded that corrective surgery improves cardiopul-
monary function. Malek et al [3] studied 21 patients and
showed the oxygen pulse and maximum oxygen uptake
in these patients were significantly lower than reference
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pectus excavatum deformity with extreme leftward dis-
placement of the heart, which compressed the IVC at
the level of the diaphragm, causing reduced stroke
volume of the right heart. By contrast, some authors
have related the cardiopulmonary symptoms to psycho-
logical effects in this young group of patients who are
hesitant to participate in social events and sports
actively [5-7]. Thus, there is no consensus among inves-
tigators on the existence or degree of cardiopulmonary
impairment in pectus excavatum patients. The clinical
significance of the physiological findings in pectus exca-
vatum patients has remained controversial [8,9] leading
some to consider corrective surgery a cosmetic
procedure.
Currently, radiographic studies such as chest X-ray or
CT scan are used to quantify the severity of chest wall
deformity by deriving the pectus index (PI). PI, else-
where called pectus severity index, is defined at the level
of greatest deformity as the maximum transverse dia-
meter of the chest divided by the shortest distance
between the posterior edge of the indented sternum and
the anterior border of the vertebral bodies of the thor-
acic spine [10,11]. PI is used as a criterion in evaluating
patients for surgery, but it has not been shown to have
any correlation with stroke volume or even subjective
feeling of improvement after correction [12]. On the
other hand, the pathophysiology of pectus excavatum
patients has been attributed to cardiac displacement as
well as the degree and shape of chest deformity and
patient age [13].
Chest x-rays and CT scans continue to be used mainly
to assess the degree of deformity in pectus excavatum
patients but both tests expose patients to ionizing radia-
tion. Other investigations such as pulmonary function
tests, maximal exercise tests, arterial blood gases and
echocardiography, have also been used to evaluate
patients with pectus excavatum. However, they may lack
the sensitivity to detect anatomical and subtle pathophy-
siological abnormalities. Thus, there is a clinical need
for additional objective assessment.
Recent technical developments in cardiovascular mag-
netic resonance (CMR) and the range of its applications
have highlighted the potential of this modality as a reli-
able, non-invasive diagnostic tool. CMR is powerful for
the assessment of chest and cardiac anatomy, cardiac
function, pulmonary vascular anatomy and perfusion,
blood flow and blood circulation times.
To our knowledge, no study has used CMR for assess-
ment of patients with pectus excavatum. The purpose of
our study, therefore, was to assess resting cardiovascular
anatomy and function in patients with pectus excavatum
using CMR and compare the results with healthy con-
trol subjects.
Method and materials
Study population
Our study population was a group of patients referred
or self-referred for evaluation of pectus excavatum.
Between August 2004 and January 2008, they were
offered the opportunity to participate in a broader study
designed to evaluate cardiovascular structure and func-
tion using conventional pulmonary function tests and
exercise tests as well as imaging. Thirty consecutive
patients who enrolled in the broader study and had
CMR scans were included in this analysis. The group
with pectus excavatum deformity consisted of 23 men
and 7 women aged 24.3 ± 13.3 years (age ± SD). Their
CMR studies were compared to those from a conveni-
ence sample of 25 healthy adult controls within
the same age range (18 men, 7 women), aged 24.1 ± 3.8
years, without chest wall deformity or any other cardio-
vascular or pulmonary disease.
CMR
Apparatus and Setup
All studies were performedo na3 2c h a n n e l1 . 5T e s l a
scanner (Magnetom Avanto, Siemens Medical Solutions,
Malvern, PA) using combined 24-element spine coil and
6-element body phased array coil. CMR compatible
ECG electrodes were positioned on the anterior chest
and a 22-gage intravenous cannula was sited in an ante-
cubital vein for subsequent infusion of CMR contrast
medium. Subjects were positioned supine on the scan-
ner table and advanced head first into the magnet bore.
From 2004-2006, the CMR contrast used was gadodia-
mide 0.15 mmol/kg (GE - Amersham Health Inc. Prin-
ceton, NJ) and after this date Magnevist (Berlex
Labratories, Wayne, NJ) was used at a lower dose
(0.1 mmmole/Kg). This contrast was administered as a
controlled, timed infusion using an electronic injector
(Spectris, Medrad Inc. Pittsburg, PA).
Overview of the CMR Protocol
The following CMR protocol was employed for assess-
ment of cardiopulmonary structure and function. After
obtaining scout images, detailed anatomical images were
acquired to derive chest wall diameters, pectus severity
index, and indices of chest and cardiac distortion. Next,
4-chamber, right and left ventricular outflow tract
(RVOT and LVOT) and short-axis cine images were
obtained to quantify bi-ventricular function. Dynamic
pulmonary parenchymal enhancement and pulmonary-
systemic circulation times were then evaluated
using low-dose, time-resolved 3D MR angiography with
0.035 mmol/kg gadolinium at a 3D sampling interval of
1.5 seconds. Subsequently, high-spatial-resolution con-
trast enhanced MR angiography was acquired to visua-
lize detailed pulmonary vascular anatomy. Finally, blood
flow in the main pulmonary artery was quantified with
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dual sequences are outlined below.
Anatomical Imaging
A series of large field-of-view (FOV), single-shot, steady-
state-free-precession (SSFP) survey images [15] were
obtained in coronal, sagittal and transverse planes cover-
ing the entire chest and upper abdomen. The following
sequence parameters were used: TR/TE = 3.0/1.4 msec
and flip angle 70-80°. Accelerated parallel acquisition
(generalized autocalibrating partially parallel acquisitions
[GRAPPA×2]) [16] was used for enhanced acquisition
speed. An average of 40-70 slices (depending on the
orientation of the plane and patient size) at 5-6 mm
increments were acquired during 14-17 seconds of non-
breath hold acquisition.
Cine CMR
A stack of short axis cine (SSFP) images (10-12 short
adjacent slice positions) were acquired during indivi-
dual 5-6 second breath-holds, encompassing the atrio-
ventricular valve plane to the cardiac apex, followed by
cine images in the four-chamber, LV vertical long axis,
RVOT, LVOT views and the midline sagittal plane
(through the region of minimum sterno-spinal
distance). A segmented k-space SSFP sequence as
previously described [17] was employed with retrospec-
tive ECG-gating. Imaging parameters were TR/TE =
2.8/1.2 msec, flip angle = 70°, GRAPPA×2 and 6 mm
slice thickness with a temporal frame duration of 30-
43 msec.
Dynamic, Time-Resolved 3D MR Angiography
We assessed dynamic pulmonary enhancement as an
index of regional lung perfusion using an ultra fast 3D,
spoiled GRE sequence [18] with temporal echo sharing
[19] (TR/TE 2.5/1, FA 20°). Data acquisition started
simultaneously with injection of (6 cc) contrast agent at
a rate of 4 ml/sec followed by 20 ml of saline flush with
the same rate. 10-14 sequential measurements were
acquired at a rate of one frame per 1.5 seconds while
subjects held their breath in inspiration. Maximum
intensity projection (MIP) reconstruction was performed
online and was available for immediate assessment of
global vascular anatomy and pulmonary-systemic circu-
lation times.
Contrast Enhanced MR Angiography
Dual-phase, high-spatial resolution contrast enhanced
MR angiography of the pulmonary vasculature was sub-
sequently acquired using a 3D spoiled gradient-recalled-
echo (GRE) sequence (TR/TE: 2.6/0.9 ms, FA: 30°,
GRAPPA×3). Gd contrast was infused at a rate of
1.5 ml/sec followed by 30 ml of saline flush at the same
rate. A 3D dataset was acquired during 20-22 seconds
while subjects held their breath. The entire thorax was
interrogated during these acquisitions with voxel dimen-
sions of 1.3 × 1.0 × 1.2 mm³.
Velocity Encoded Cine Flow Imaging of the Main Pulmonary
Artery
Phase-sensitive velocity encoded cine [20,21] quantified
main pulmonary artery flow indices for comparison in
both groups. The sequence parameters were TR/TE
55/2.9 ms, FA 20
°and GRAPPA×2. Images were retro-
spectively ECG gated with 5 segments per heartbeat and
20 calculated phases. Images were acquired during
18-20 seconds of breath-hold acquisition. The velocity
mapping sequence had single direction (through-slice)
flow encoding with an aliasing velocity of 150 cm/sec.
Two perpendicular RVOT cine images were used to
determine the optimal imaging plane. A perpendicular
plane to the MPA midway between the pulmonary valve
and bifurcation was used.
Image Analysis
The MR images were transferred to a 3D workstation
(Leonardo, Siemens Medical Solutions, Malvern, PA) for
measurement of the following data:
Thoracic dimensions Transverse survey images were
interrogated by the lead author who has five years of
experience in CMR and data processing, to measure the
maximum transverse diameter and minimum sterno-
spinal distance, at the level of greatest sternal depression
(Figure 1A). The CMR-derived pectus index (chest
index) as defined by Raichura et al. [5,22,23] was deter-
mined as:
Max transverse diameter
Sternospinal dis ce tan
.C h e s tw a l lf l a t n e s s
was defined using the Nakahara method [10] as the
ratio of maximum internal transverse diameter of the
thorax to maximum antero-posterior rib diameters on
the right and left hemithorax, respectively, at the level
of greatest deformity. Additionally, axial images were
used to measure the degree of cardiac left-lateral shift.
The maximum lateral distances of the left (LDL)a n d
right (LDR ) cardiac borders were measured from the
midline (sterno-spinal line). Then cardiac left lateral
shift (%) was measured as ()
LD
LD LD
L
LR +
.B o t hL D L and
LDR were measured perpendicular to the sterno-spinal
line (Figure 1).
Cardiac Function Short axis cine images (Figure 2)
were assessed by the lead author using commercial car-
diac analysis software (Argus, Siemens Medical Solu-
tions) for derivation of cardiac hemodynamic indices.
To correct for potential through-plane movement at the
cardiac base (because of longitudinal shortening during
the cardiac cycle), a manual slice following method was
employed. The horizontal long-axis and RVOT were
used to display the position of each short-axis cine slice,
during the full cardiac cycle. Then images at end-systole
(ES) and end-diastole (ED) phases were re-referenced
based on the longitudinal shortening of both ventricles.
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for LV structural assessment whereas only the endocar-
dium was traced for RV volume assessment. End-diasto-
lic volume (EDV), end-systolic volume (ESV), EF, stroke
volume (SV) and cardiac output (Qc) were calculated,
based on the contoured images. Measurements were
normalized to body surface area and used for compara-
tive analysis between patients with pectus excavatum
and controls. RV contouring is more subjective and
error-prone, so we assessed the possible measurement
error in the calculation of RV volumes based on the dis-
crepancy in LV and RV stroke volumes (SVLV,S V RV)
for both groups (SVLV -S V RV). Furthermore, to evaluate
myocardial contractile properties, long and short dimen-
sions (LD and SD) of the right and left ventricles were
measured during both ED and ES phases at the level of
mid ventricle to calculate regional myocardial shorten-
ing (
ED ES
ED
dd
d
−
).
In addition to quantitative measurement of cardiac
function, all cine images were assessed qualitatively by
two radiologists. Both ventricles were assessed for wall
motion abnormalities, aneurysm, chamber enlargement,
hypertrophy or wall thinning.
Pulmonary-Systemic Circulation Time
We used dynamic time-resolved MRA of the chest to
evaluate pulmonary-systemic circulation times and con-
trast dispersion in the aorta. Francois et al and Shors
et al [24,25] showed that cardio-pulmonary circulation
times are prolonged in heart disease, and the degree of
prolongation is related to the severity of systolic ventricu-
lar dysfunction. Therefore, we performed quantitative
analysis of pulmonary-systemic circulation times, based
on interrogation of the 3D-Time Resolved images using a
Mean Curve software algorithm on a commercial work-
station (Leonardo, Siemens Medical Solutions). One
region of interest (ROI) was placed on the ascending
a o r t aa n da n o t h e ro nt h ep u l m o n a r ya r t e r yt r u n k .T h e
software outputs the signal versus time curves for both
ROIs. Pulmonary-systemic circulation time was defined
as the time between peak pulmonary artery enhancement
and peak aortic enhancement. Moreover, dispersion of
contrast in the aorta was measured as the width of the
ascending aorta curve at half its peak signal intensity
(FWHM = full width half maximum). (Figure 3)
Pulmonary perfusion Pulmonary parenchymal enhance-
ment was assessed for symmetry and existence of any
perfusion deficits by two observers in four anatomical
Figure 1 Chest wall measurements of a 16 year old male with
severe pectus excavatum deformity. A Transverse TrueFISP (SSFP)
images (TR/TE 630.5/1.4 msec, FA 80°): (a) minimum antero-posterior
diameter of the chest (1.2 cm), (b) maximum transverse diameter of
the chest (28.2 cm); (c) antero-posterior diameter of the left
hemithorax (12.0 cm), (d) antero-posterior diameter of the right
hemithorax (11.5 cm). The pectus index (b/a) in this case was 22.9,
left chest flatness (b/c) was 2.35 and right chest flatness (b/d) was
2.44. B Transverse image showing complete (100%) leftward shift of
the heart into left hemithorax. The maximum lateral distances of the
left (LDL = 15.02 cm) and right (LDR = 0 cm) cardiac borders were
measured from the midline (sterno-spinal line). Then cardiac left
lateral shift (%) was measured as ()
LD
LD LD
L
LR +
×100. C Coronal TrueFISP
image (TR/TE 630.5/1.4; msec, FA 80°) in same patient showing
derivation of the indices of cardiac flatness: maximum horizontal
diameter of the chest (e) which was 27.8 cm, maximum horizontal
diameter of the heart (f) which was 14.8 cm and cardiac flatness (f/
e) which was 0.53. D Sagittal image showing minimum AP diameter
of the chest. Figure 1E-H Chest wall measurements in a 23 year old
healthy subject male. E Transverse TrueFISP (SSFP) images (TR/TE
630.5/1.4; msec, FA 80°): (a) minimum antero-posterior diameter of
the chest (9.07 cm), (b) maximum transverse diameter of the chest
(24.7 cm); (c) antero-posterior diameter of the left hemithorax (13.3
cm), (d) antero-posterior diameter of the right hemithorax (13.0 cm).
The chest index (b/a) in this case was 2.1, left chest flatness (b/c)
was 1.8 and right chest flatness (b/d) was 1.9. F Transverse image
showing leftward shift (67%) of the heart into left hemithorax. The
maximum lateral distances of the left and right cardiac borders
were measured as: LDL = 8.71 cm and LDR = 3.97 cm. G and H are
coronal and sagittal TrueFISP images in this healthy subject.
Figure 2 Cardiac cine images (TR/TE 29.4/1.2, FA 65°) of a 18
year old male with pectus deformity (pectus index being 17.9)
and symptoms of exersional dyspnea. He has also noted
discomfort in the lower anterior chest with activity and has
experienced tachypnea and tachycardia. The heart is deviated
considerably into the left chest by the depressed sternum. Note the
restricted dilation at the end-diastolic phase.
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lungs).
Pulmonary Angiographic Anatomy Assessment of
thoracic vascular anatomy was performed by two obser-
vers in different sessions, using high-spatial-resolution
pulmonary MR angiography and cardiac cine images.
Processing was performed on a 3D workstation (Leo-
nardo, Siemens Medical Solutions, Malvern, PA), using
a maximum intensity projection (MIP) algorithm. The
3D volume source images were reconstructed into over-
lapping thin (10 mm) MIP sub-volumes (Figure 4). Pul-
monary trunk, main and lobar arteries on MRA images
and MIP reconstructed images were assessed for exis-
tence of any degree of abnormalities (e.g. aneurysm,
stenosis).
Flow Measurement in the Main Pulmonary Artery In
the main pulmonary artery, the following measurements
were performed: peak and average velocity, peak and
average volume flow (as product of mean or peak blood
velocity by cross-sectional area), and net forward
volumes (integrated forward volume flow) [14].
Statistical Analysis
A two-tailed t-test was used to compare chest indices,
cardiac indices, pulmonary flow measurements and
pulmonary-systemic circulation times between patients
with pectus excavatum and controls. In addition, the
Kolmogrorov-Smironov Test was used to compare the
distribution of measurement error for left and right
ventricular EF and RVsv. Chest indices were correlated
with ventricular EF using Pearson correlation. A corre-
lation coefficient (r) greater than 0.6 was considered to
be a strong correlation. Inter-observer agreement
between readers for the assessment of thoracic struc-
ture and cardiac function was determined by calculat-
ing the kappa coefficient. (poor agreement,  =0 ;
slight agreement,  = 0.01-0.2; fair agreement,  =
0.21-0.4; moderate agreement,  = 0.41-0.6; good
agreement,  = 0.61-0.8; and excellent agreement,  =
0.81-1) [26,27]. At all comparisons, P < 0.05 was con-
sidered to indicate a statistically significant difference.
Data analysis was performed using SPSS 13, 2004
(SPSS Inc, Chicago, IL) statistical package. The chest
indices, cardiac indices, pulmonary flow measurements,
and pulmonary-systemic circulation times were plotted
as mean ± SD.
Ethical Considerations
This HIPAA compliant study was approved by the
Institutional Review Board of the David Geffen School
of Medicine, University of California, Los Angeles.
Written informed consent was obtained for all study
subjects.
Figure 3 Pulmonary perfusion in same patient as in figure one. Coronary time resolved images (TR/TE, FA) show a symmetric pulmonary
perfusion with no perfusion deficits and normal cardio-pulmonary transit times in the most severe case among our patients with pectus severity
index of 22.9.
Figure 4 Contrast enhanced high-resolution MR angiography
(TR/TE 2.7/0.9, FA 70°) of a 17-year-old female with a pectus
severity index of 7.9 and experience of increasing shortness of
breath with exercise. 15 mm thickness maximum intensity
projection images are made with an increment of 1 mm and 9 mm
overlap. Images show the normal distribution of the pulmonary
vessels with no abnormality. Pulmonary branches are completely
assessable up to the 5
th branch order.
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Chest wall measurements and indices
Chest wall measurements and all indices are summar-
ized in Table 1. As expected, there was a significantly
lower minimum sterno-spinal distance in pectus excava-
tum patients (3.6 ± 1.7 cm) compared with controls (9.1
± 1.6 cm; P < 0.001). Right and left hemithorax maxi-
mum AP rib diameters were also lower than controls
(P < 0.01). The chest wall index was three times higher
in pectus excavatum patients (mean ± SD in pectus
excavatum patients 9.3 ± 5.0, ranging from mild (3.7) to
av e r ys e v e r ed e f o r m i t y( 2 2 . 9 )v e r s u s2 . 8±0 . 4i nt h e
control group ranging from 2.1 to 3.9 (P < 0.001). The
i n c l u s i o nc r i t e r i af o rt h em a j o rs t u d ys t i p u l a t eac h e s t
wall index or pectus index (PI) >3.5. Likewise, chest flat-
ness was significantly greater in pectus excavatum
patients (2.2 ± 0.2 and 2.1 ± 0.2 for right and left CF
respectively) than in controls (1.7 ± 0.2 and 1.8 ± 0.2
for right and left CF respectively, P < 0.001). Cardiac
left lateral shift (%) was significantly higher in pectus
excavatum patients (83.9% ± 13.6) compared to the con-
trols (65.2% ± 5.8; P < 0.001).
Cardiac Hemodynamic Indices
Quantitative cardiac functional indices, mean ± SD, both
absolute and normalized to body surface area (BSA), are
presented in Table 2. Both left- and right-ventricular
ejection fractions (LVEF and RVEF) were lower in
patients compared to controls. RVEF achieved a statisti-
cally significant difference of approximately 6% (mean ±
SD in pectus excavatum patients 53.9 ± 9.6 versus 60.5
± 9.5% in controls P = 0.013) when compared to the
control group. Furthermore, a Kolmogorov-Smirnov
Test used to compare the distribution of measurement
error for both groups, failed to show a significant differ-
ence (P > 0.05). RV End-systolic volume (ESV) was sig-
nificantly higher in pectus excavatum patients (mean of
normalized value ± SD for pectus excavatum patients
were 30.8 ± 10.5 versus 23.9 ± 7.5 ml in controls; P =
0.006). Measurement error between both groups was
not significantly different from each other (P > 0.05).
The RV short dimension was significantly less both at
end-diastole (ED) (pectus excavatum versus control: 22.6
± 7.0 mm and 33.6 ± 4.6 mm, P < 0.001) and end-systole
(ES) (18.9 ± 5.9 mm versus 26.7 ± 4.3 mm, P < 0.002).
The RV long dimension was significantly greater at ED
(79.1 ± 9.6 mm versus 73.3 ± 9.0 mm for pectus excava-
tum patients and controls respectively; P = 0.047). The
short diameter RV shortening was significantly less in pec-
tus excavatum patients (pectus excavatum versus control:
14.8 ± 9.3 versus 20.4 ± 8.5, P = 0.043) and the long dia-
meter RV shortening was significantly greater in pectus
excavatum patients (pectus excavatum versus control: 17.4
± 5.5 versus 13.4 ± 3.9, P = 0.007) (Figure 5). However, we
did not detect any significant differences in these measures
at ES (P > 0.512). We did not detect any significant
Table 1 Summary of chest and cardiac dimensions and indices
Pectus patients Healthy Subjects
Mean ± SD Mean ± SD P-value
Age (year) 24.3 ± 13.3 24.1 ± 3.8 0.770
Height (meter) 1.8 ± 0.1 1.7 ± 0.07 0.253
Weight (Kg) 67.1 ± 11.7 72.2 ± 14 0.054
BSA 1.8 ± 0.2 1.9 ± 0.2 0.055
Chest Diameters and Indices
Minimum sterno-spinal distance (cm) 3.6 ± 1.7 9.1 ± 1.6 < 0.001
Maximum transverse diameter (cm) 26.4 ± 2.1 25.1 ± 2.0 0.057
Chest Index/Pectus Severity Index (PSI) 9.3 ± 5.0 2.8 ± 0.4 < 0.001
Right chest maximum AP diameter (cm) 12.2 ± 1.6 14.5 ± 1.7 < 0.001
Left chest maximum AP diameter (cm) 12.6 ± 1.6 14.2 ± 2.0 0.003
Right chest flatness 2.2 ± 0.2 1.7 ± 0.2 < 0.001
Left chest flatness 2.1 ± 0.2 1.8 ± 0.2 < 0.001
Coronal maximum transverse diameter (cm) 25.7 ± 3.2 24.3 ± 1.0 0.072
Coronal maximum diameter of the heart (cm) 14.4 ± 2.3 12.8 ± 1.4 < 0.001
Cardio-Thoracic Ratio (Cardiac Flatness) 0.6 ± 0.3 0.5 ± 0.04 0.154
Cardiac Shift
Right Border of heart to midline (cm) 2.7 ± 2.1 4.3 ± 0.7 < 0.001
Left Border of heart to midline (cm) 11.6 ± 1.6 8.1 ± 1.3 < 0.001
Cardiac Left Lateral Shift (%) 83.9 ± 13.6 65.2 ± 5.8 < 0.001
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their myocardial shortening (P > 0.2) Table 3.
We did not detect any significant correlation between
the RVEF or LVEF and pectus index. (For RVEF r =
-0.2061 (95% confidence interval -0.5272 to 0.1666), P =
0.2746; For LVEF r = -0.0065 (95% confidence interval
-0.3659 to 0.3546) P = 0.9727).
Pulmonary Perfusion and Pulmonary-Systemic Circulation
Time
All dynamic 3-D MR angiographic studies showed sym-
metrical perfusion in both lungs, with no filling defects.
There was no difference between both readers for pul-
monary perfusion assessments.
Table 2 Cardiac Hemodynamic Indices
Pectus patients Healthy Subjects
Mean ± SD Range Mean ± SD Range P-value
Left Ventricle ABSOLUTE EF (%) 66.1 ± 6.6 56.3 - 82.6 69.7 ± 6.9 54.4 ± 82.5 0.059
EDV (mL) 113.5 ± 22.8 67.6 - 164.7 111.4 ± 29.9 56.4 ± 202.3 0.620
ESV (mL) 38.4 ± 10.9 13.7 - 59.6 34.3 ± 15.2 15.8 ± 92.4 0.182
Myocardial Mass (g) 122.2 ± 32.1 66.4 - 211.3 117.9 ± 34.4 25.6 ± 188.2 0.287
SV (mL) 75.0 ± 16.1 43.5 - 110.2 76.9 ± 19.1 37.1 ± 115.9 0.782
CO (l/min) 5.03 ± 1.3 3.2 - 9.3 4.8 ± 1.1 2.5 ± 6.5 0.427
NORMALIZED (units/m^2) EDV (mL) 61.7 ± 12 40.5 - 81.9 60.2 ± 13.7 37.2 ± 95.9 0.564
ESV (mL) 21.4 ± 6.4 7.0 - 34.4 18.5 ± 7.2 7.7 ± 43.8 0.127
Myocardial Mass (g) 65.8 ± 13.5 38.2 - 91.7 60.2 ± 17.5 13.9 ± 89.2 0.602
SV (mL) 40.8 ± 7.7 24.7 - 61.5 41.7 ± 9.1 24.4 ± 63.7 0.703
CI 2.7 ± 0.6 1.85 - 4.01 2.6 ± 0.6 1.6 ± 3.7 0.421
Right Ventricle ABSOLUTE EF (%) 53.9 ± 9.6 33.9 - 73.0 60.5 ± 9.5 42.3 ± 80.8 0.013
EDV (mL) 122.1 ± 30.5 63.8 - 168.6 114.9 ± 36.4 57.1 ± 240.0 0.370
ESV (mL) 56.5 ± 18.8 28.8 - 98.1 44.6 ± 17.2 23.3 ± 108.5 0.014
SV (mL) 65.6 ± 19.3 27.9 - 103.9 69.9 ± 24.8 21.7 ± 138.4 0.555
CO (l/min) 4.3 ± 1.3 2.3 - 8.6 4.3 ± 1.5 1.4 ± 8.2 0.896
NORMALIZED (units/m^2) EDV (mL) 66.3 ± 16.2 36.7 - 97.1 61.9 ± 16.9 34.3 ± 115.1 0.306
ESV (mL) 30.8 ± 10.5 14.3 - 54.3 23.9 ± 7.5 11.4 ± 51.5 0.006
SV (mL) 35.4 ± 9.8 16 - 58.8 37.9 ± 12.8 14.3 ± 65.7 0.465
CI 2.3 ± 0.6 1.2 - 3.6 2.3 ± 0.8 0.9 ± 4.4 0.987
EF = Ejection Fraction; EDV = End Diastolic Volume; ESV = End Systolic Volume; SV = Stroke Volume; CO = Cardiac Output; CI = Cardiac Index
Figure 5 Comparison of right ventricle myocardial shortening
in the direction of short and long diameters between patients
with pectus excavatum and healthy control subjects.
Table 3 Ventricular diameters and shortening indices
(mean ± SD) based on mid-ventricle short-axis cine
images
Pectus patients Healthy Subjects P-value
Ventricular Diameters during cardiac phases (mm)
RV-SD ED 22.6 ± 7.0 33.6 ± 4.6 <0.001
ES 18.9 ± 5.9 26.7 ± 4.3 <0.002
RV-LD ED 79.1 ± 9.6 73.3 ± 9.0 0.047
ES 65.4 ± 9.0 63.6 ± 8.9 0.512
LV-SD ED 45.6 ± 5.9 46.6 ± 4.7 0.517
ES 30.2 ± 4.5 31.67 ± 4.1 0.259
LV-LD ED 54.7 ± 6.4 55.4 ± 3.9 0.618
ES 35.8 ± 4.8 36.0 ± 4.7 0.857
Myocardial Shortening (%)
RV-SD shortening 14.8 ± 9.3 20.4 ± 8.5 0.043
RV-LD shortening 17.4 ± 5.5 13.4 ± 3.9 0.007
LV-SD shortening 33.6 ± 6.6 32.0 ± 5.9 0.404
LV-LD shortening 34.3 ± 6.7 34.9 ± 6.9 0.766
RV-SD = right ventricle short diameter; RV-LD = right ventricle long diameter;
LV-SD = left ventricle short diameter; LV-LD = left ventricle long diameter; ED
= end diastole; ES = end systole
Saleh et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:73
http://www.jcmr-online.com/content/12/1/73
Page 7 of 10Pulmonary-systemic circulation times in pectus exca-
vatum patients were not significantly different (mean ±
SD for pulmonary-systemic circulation time and FWHM
in pectus excavatum patients was 6.3 ± 1.1 and 6.7 ±
1.0 seconds respectively, versus 6.6 ± 0.5 and 6.5 ±
1.1 seconds in controls; for both P > 0.2).
Pulmonary Vascular Anatomy
One patient had an enlarged pulmonary artery trunk
(3.2 cm), detected by both readers but no other vascular
abnormality. Another patient had dextrocardia but no
evidence of valvular or cardiac septal abnormality.
Observing that this patient did have cardiac compres-
sion caused by the pectus deformity, we chose to not to
exclude him/her from the overall analysis. The remain-
ing patients were diagnosed with normal pulmonary vas-
cular anatomy by both readers independently ( = 1).
Pulmonary Artery Flow Indices
Average flow and net forward volume indexed to BSA
tended to be greater in patients; however, the differences
failed to reach statistical significance (P = 0.070 and P =
0.386 respectively). The results showed no significant
difference for all other flow parameters (P > 0.1). Quan-
titative pulmonary artery flow measurements for both
patients and controls are summarized in Table 4.
Discussion
The results of our study show that, compared with con-
trols, patients with pectus excavatum deformity have
reduced RV short axis diameter, increased RV long axis
diameter and reduced RV ejection fraction. These find-
ings likely reflect compression induced changes in RV
anatomy and changes in the pattern of myocardial
shortening in patients with pectus excavatum, poten-
tially mimicking restrictive RV physiology. No
differences were found in LV ejection fraction, LV myo-
cardial shortening, aorto-pulmonary circulation time or
pulmonary flow indices between pectus excavatum
patients and controls.
Most of our patients presented with complaints of
increasing dyspnea with mild exercise or a decrease in
stamina and endurance. Some physicians have sug-
gested that these symptoms and their improvement
after corrective surgery are, at least in part, psychologi-
cal [5,6]. Others have demonstrated that patients with
pectus excavatum have true physiological impairments
[3] and some studies report increased exercise toler-
ance and higher oxygen pulse after corrective surgery
[2]. In our study, patients with pectus excavatum had
slightly lower RVEF compared to the healthy control
group, which did not show any significant difference in
their distribution from the control group. While CMR
can provide a very good visualization and measure-
ment of LV volumes, RV volume measurements are
more challenging. RV contouring is more challenging,
because of the thinner wall, widespread trabeculation
and geometrically non-uniform shape. RVOT imaging
becomes even more difficult when the RV is distorted
by sternal compression and this can exacerbate error
in RV volume measurement. Nevertheless, we found
same systematic error of stroke volume discrepancy in
LV and RV between both groups (P = 0.510). The
reduced RVEF could be explained by the higher ESV
in pectus excavatum patients, implying altered myocar-
dial contractility rather than RV restriction by direct
sternal depression. The RV wall is very thin and most
of the myocardial thickening occurs in the trabeculated
portion [28]. If this portion is incompletely segmented
from the blood pool, the measured end systolic
blood volume will be increased. Meticulous contouring
is therefore, important to minimize errors in
measurement.
Our results show that RV myocardial shortening was
significantly different in patients with pectus excavatum
compared with controls. Myocardial shortening and
thus contractility in the direction of the short-diameter
(SD) in short axis cine was reduced, whereas myocardial
shortening in the direction of the long-diameter (LD)
was increased. It appears that this is a compensatory
mechanism in order to preserve RVEF.
We did not detect any significant correlation between
the EF and pectus severity index, which could poten-
tially be explained by chest reconfiguration (i.e. an
increase in maximum transverse diameter of the chest)
and cardiac left lateral shift, which could be another
compensatory mechanism to avoid the direct restrictive
impairment of the right heart. Furthermore, pectus
excavatum patients did not show significant changes in
pulmonary flow quantification.
Table 4 Pulmonary trunk assessment for dimensions and
flow measurements (mean ± SD)
Pectus
Patients
Healthy
Subjects
P-
value
Pulmonary Artery Diameter
(cm)
2.18 ± 0.2 2.13 ± 0.1 0.574
Average Cross-sectional Area
(cm
2)
6.2 ± 1.0 6.1 ± 0.9 0.623
Average Velocity (cm/sec) 16.5 ± 4.4 15.0 ± 2.0 0.175
Peak Velocity (cm/sec) 78.9 ± 21.0 75.2 ± 14.0 0.542
Average Flow (ml/m) 101.0 ± 16.0 89.0 ± 15.6 0.070
Average Flow/min (l/min) 5.9 ± 0.9 5.3 ± 0.9 0.121
Forward Volume (ml) 86.1 ± 18.3 79.6 ± 18.1 0.405
Reverse Volume (ml) 0.2 ± 0.5 0.2 ± 0.3 0.615
Net Forward Volume (ml) 86.1 ± 18.9 79.4 ± 17.9 0.386
Net Forward Volume/BSA
(ml/m
2)
47.3 ± 10.7 43.4 ± 7.6 0.299
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Our study has certain limitations. Firstly, it was not
strictly a case-control design and the normal comparison
group was only matched in terms of age range. They
were, however, healthy volunteers without any history of
cardiovascular or lung disease and without any chest wall
deformity. Furthermore, we detected no abnormalities on
CMR scanning in this group. Secondly, while CMR can
provide a very good visualization and measurement of
LV volumes, RV contouring and volume measurements
can be more challenging. This is because of the thinner
wall, widespread trabeculation and geometrically non-
uniform shape. RVOT imaging becomes even more diffi-
cult when the RV is distorted by sternal compression and
this can exacerbate error in RV volume measurement.
Finally, patients with severe pectus excavatum deformity
(or even moderate pectus excavatum deformity) may be
different from the mild forms in terms of cardiopulmon-
ary function as quoted by Haller et al [2]. Unfortunately,
given the relatively small numbers of subjects, especially
with very severe pectus excavatum, we were unable to
stratify patients according to the severity of pectus exca-
vatum. We did, however look for correlations between PI
and both LVEF and RVEF but found none. However, this
could reflect the fact that PI is not such a satisfactory
means of assessing the severity of pectus excavatum and
that other measures reported in this paper might be
more promising for future research investigations.
Conclusion
Patients with pectus excavatum deformity show varying
levels of distortion of the right ventricle, associated with
a 6% reduction in resting RVEF relative to controls. The
degree of physiological impairment is likely related to
the degree of geometrical distortion of the RV due to
the sternal compression, and it is possible that, in some
patients, restrictive physiology plays a role. Further work
is warranted to assess whether these changes are reversi-
ble with corrective surgery.
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